Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shugan Granules for anxiety and depression state (liver qi stagnation syndrome)
ChiCTR1800019175Phase 4Not yet recruiting
- Sponsor
- Beijing University of Chinese Medicine East Hospital
- Start
- Sep 2018
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in anxiety disorder and major depressive disorder (MDD) comparing Shugan Granules with Placebo comparator (2 arms). Primary endpoint: Change from baseline in Hamilton Anxiety Scale total score at 8 weeks. Planned start Sep 2018; status: not yet recruiting.
02
Drugs
shugan granules
03
Conditions
anxiety disordermajor depressive disorder (MDD)
Beyond the preview
Go deeper on ChiCTR1800019175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800019175.